Two further known prognostic factors associated with tumor aggressiveness, proliferative activity, disease spread rates and risk of recurrence are human epidermal growth factor receptor 2 (HER2) and Ki-67 overexpression [34,35]. Here, ERBB2 is linked to neoplasm.